Behavioral and Clinical Factors Associated with Self-Reported Abnormal Papanicolaou Tests in Rheumatoid Arthritis

Journal of Women's Health

Volumn 23, Issue 9, 2014, Pages 771-776

  Gillet, Victoria G ^a   Solomon, Daniel H ^a,b   Shadick, Nancy A ^b   Weinblatt, Michael E ^b   Iannaccone, Christine K ^b   Feldman, Sarah ^c   Kim, Seoyoung C ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CONTRACEPTIVE BEHAVIOR; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SELF REPORT; SEXUALLY TRANSMITTED DISEASE; STRUCTURED QUESTIONNAIRE; ARTHRITIS, RHEUMATOID; COMPLICATION; CONFIDENCE INTERVAL; HEALTH BEHAVIOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; RISK; RISK FACTOR; SEXUALLY TRANSMITTED DISEASES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTHRITIS, RHEUMATOID; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PAPANICOLAOU TEST; QUESTIONNAIRES; RISK FACTORS; SELF REPORT; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84921668054     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4658     Document Type: Article

References (18)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clinic 2013;63:11-30.
2. Howlader N, Noone AM, Krapcho M, et al. Surveillance, Epidemiology, and End Results (SEER) Program. SEER stat fact sheets: Cervix uteri. SEER Cancer Statistics Review, 1975-2009. National Cancer Institute, 2012. Available at http://seer.cancer.gov/statfacts/html/cervix.html. Accessed October 2, 2012.
3. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm Rep 2007;56(RR-2):1-24.
4. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New Engl J Med 1998;338:423-428.
5. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002;94: 1406-1414.
6. Rojo Contreras W, Montoya Fuentes H, Gamez Nava JI, et al. [Prevalence and cervical human papilloma virus associated factors in patients with rheumatoid arthritis]. Ginecol Obstet Mex 2008;76:9-17.
7. Rojo-Contreras W, Olivas-Flores EM, Gamez-Nava JI, et al. Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis. Lupus 2012;21:365-372.
8. Santana IU, Gomes Ado N, Lyrio LD, Rios Grassi MF, Santiago MB. Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review. Clinical Rheumatology 2011;30: 665-672.
9. Kim SC, Glynn RJ, Giovannucci E, et al. Risk of highgrade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Annals of the rheumatic diseases. Mar 11 2014. doi: 10.1136/annrheumdis-2013-204993. [Epub ahead of print].
10. Suris JC, Resnick MD, Cassuto N, Blum RW. Sexual behavior of adolescents with chronic disease and disability. J Adolesc Health 1996;19:124-131.
11. Suris JC, Michaud PA, Akre C, Sawyer SM. Health risk behaviors in adolescents with chronic conditions. Pediatrics 2008;122:e1113-1118.
12. Valencia LS, Cromer BA. Sexual activity and other highrisk behaviors in adolescents with chronic illness: a review. J Pediatr Adolesc Gynecol 2000;13:53-64.
13. Iannaccone CK, Lee YC, Cui J, et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: Data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford) 2011;50:40-46.
14. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42: 377-381.
15. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System. Available at www .cdc.gov/brfss Accessed April 3, 2013.
16. Nelson W, Moser RP, Gaffey A, Waldron W. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: Data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health (Larchmt) 2009; 18:1759-1768.
17. Bernatsky S, Joseph L, Belisle P, et al. Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat Med 2005;24:2365-2379.
18. Dugue PA, Rebolj M, Garred P, Lynge E. Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther 2013;13:29-42.